News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Real-time Estimate Cboe BZX Other stock markets 09:39:44 2024-04-23 am EDT			5-day change	1st Jan Change
63.08 ^USD	+1.08%		-4.50%	-15.64%

Apr. 17	Exact Sciences Corporation announced that it has received $266.75 million in funding	CI
Apr. 15	Sector Update: Health Care Stocks Advance Premarket Monday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exact Sciences Corporation announced that it has received $266.75 million in funding	Apr. 16	CI
Sector Update: Health Care Stocks Advance Premarket Monday	Apr. 15	MT
Exact Sciences Names Aaron Bloomer CFO	Apr. 15	MT
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer	Apr. 15	BU
Exact Sciences Appoints Aaron Bloomer as Chief Financial Officer, Effective from May 15, 2024	Apr. 15	CI
Exact Sciences Corporation Announces Executive Changes	Apr. 15	CI
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	Apr. 11	MT
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes	Apr. 11	BU
Exact Sciences Corporation announced that it expects to receive $266.8 million in funding	Apr. 09	CI
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024	Apr. 08	BU
Exact Sciences Schedules First Quarter 2024 Earnings Call	Apr. 08	BU
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment	Apr. 04	BU
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer	Apr. 01	AQ
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	Mar. 28	BU
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	Mar. 28	CI
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner	Mar. 27	BU
Transcript : Exact Sciences Corporation - Special Call	Mar. 14
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study	Mar. 13	BU
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer	Mar. 07	BU
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing	Mar. 05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Summary

Filters